| Tamoxifen investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 81show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 193 trials (27 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 193 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 36 trials (11 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 15 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Ductal Carcinoma In Situ 11 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Ductal Carcinoma In Situ | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Lobular Carcinoma In Situ 7 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Lobular Carcinoma In Situ | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 7 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Invasive Breast Carcinoma 5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Invasive Breast Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Male Breast Carcinoma 5 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Male Breast Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Positive Breast Carcinoma 4 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Positive Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Fallopian Tube Neoplasm 4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Fallopian Tube Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Neoplasm 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Prostate Neoplasm 4 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Atypical Hyperplasia 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Atypical Hyperplasia | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Atypical Lobular Hyperplasia 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Atypical Lobular Hyperplasia | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ovarian Carcinomasubtype 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Ovarian Carcinoma | 3 | Observed | clinicaltrials | graph → |